Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Beth A. Chasen"'
Autor:
Peiman Habibollahi, Bruno C. Odisio, Varshana Gurusamy, Joshua D. Kuban, Rony Avritscher, Mohamed E. Abdelsalam, Beth A. Chasen, Ravi Murthy, Armeen Mahvash
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9582-9592 (2022)
Purpose: This paper aims to evaluate the safety and efficacy of the temporary redirection of blood flow of hepatoenteric collaterals using a balloon catheter in the common hepatic artery (CHA) to prevent the nontarget deposition of 90Y microspheres.
Externí odkaz:
https://doaj.org/article/b5b8121b81844d74a5baf4b88df23198
Autor:
Naoto T. Ueno, Rie K. Tahara, Takeo Fujii, James M. Reuben, Hui Gao, Babita Saigal, Anthony Lucci, Toshiaki Iwase, Nuhad K. Ibrahim, Senthil Damodaran, Yu Shen, Diane D. Liu, Gabriel N. Hortobagyi, Debu Tripathy, Bora Lim, Beth A. Chasen
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 1025-1032 (2020)
Abstract Background Radium‐223 dichloride (Ra‐223) is a targeted alpha therapy that induces localized cytotoxicity in bone metastases. We evaluated the efficacy and safety of Ra‐223 plus hormonal therapy in hormone receptor‐positive (HR+), bo
Externí odkaz:
https://doaj.org/article/cad357d50e8d4880907807ce1272c30c
Autor:
Michael T. Tetzlaff, Kelly C. Nelson, Adi Diab, Gregg A. Staerkel, Priyadharsini Nagarajan, Carlos A. Torres-Cabala, Beth A. Chasen, Jennifer A. Wargo, Victor G. Prieto, Rodabe N. Amaria, Jonathan L. Curry
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-11 (2018)
Abstract Background Immune checkpoint therapy has dramatically changed the landscape of cancer therapy, providing an efficacious and durable therapeutic option for patients with advanced-stage disease. However, dermatologic toxicities are a well-reco
Externí odkaz:
https://doaj.org/article/702c89c0e6e04f88a481332e31c49761
Autor:
Eric P. Krenning, Philippe Ruszniewski, David L. Bushnell, Andrew Eugene Hendifar, Oscar Leeuwenkamp, Paola Santoro, Beth R Chasen, Edward M. Wolin, Per Broberg, Matthew H. Kulke, Ghassan El-Haddad, Kjell Öberg, Martyn Caplin, Jonathan R. Strosberg, Richard P. Baum, Rajaventhan Srirajaskanthan
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 62, iss 12
Journal of Nuclear Medicine, 62(12), 1712-1718. Society of Nuclear Medicine and Molecular Imaging
Journal of Nuclear Medicine, 62(12), 1712-1718. Society of Nuclear Medicine and Molecular Imaging
We report the impact of 177Lu-DOTATATE treatment on abdominal pain, diarrhea, and flushing, symptoms that patients with advanced midgut neuroendocrine tumors often find burdensome. Methods: All patients enrolled in the international randomized phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e3c2d6cd0409f21dbd06f05d21eaff1
https://doi.org/10.2967/jnumed.120.258897
https://doi.org/10.2967/jnumed.120.258897
Autor:
Jonathan R, Strosberg, Rajaventhan, Srirajaskanthan, Ghassan, El-Haddad, Edward M, Wolin, Beth R, Chasen, Matthew H, Kulke, David L, Bushnell, Martyn E, Caplin, Richard P, Baum, Andrew E, Hendifar, Kjell, Öberg, Philippe, Ruszniewski, Paola, Santoro, Per, Broberg, Oscar R, Leeuwenkamp, Eric P, Krenning
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
We report the impact of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c736b9d8ebf77a75aaed9c1a021b66b
https://pubmed.ncbi.nlm.nih.gov/33771903
https://pubmed.ncbi.nlm.nih.gov/33771903